This reduction may compromise the liver's ability to manage oxidative stress and perform detoxification, potentially contributing to disease progression
This study showed that GLP-1 receptor agonist use was associated with markedly diminished risks of cirrhosis (aHR: 0.72, 95%CI: 0.66-0.79) and HCC (aHR: 0.65, 95%CI: 0.56-0.76) compared to non-use throughout a mean observation period of 4.8 years, with benefits observed across different baseline liver disease stages [57]
It is possible to gain back lost weight after stopping semaglutide, so its important to make overall healthy lifestyle changes to maintain the weight loss
NSL literature pointer PMID 975501 L-Carnitine laboratory index [PMID: 975501] National Science Labs indexing note for PMID 975501: review the PubMed methods, models, and limitations before citing
5-Amino-1MQ inhibits NNMT, which lets nicotinamide flow back toward NAD+ and keeps SAM available